CD274 and breast carcinoma: Since PD-L1 plays a critical role in breast cancer, as it is expressed at high levels by both ErbB2-positive and TNBC, and a high proportion of PD-L1-positive tumors are infiltrated with PD-1-positive lymphocytes, it can be considered as a potential target for breast cancer treatments26,27.